Diagnosis of Hepatocellular Carcinoma Using Gadoxetic Acid‐Enhanced MRI Based on LI ‐ RADS Version 2018 and LI ‐ RADS Modifications
Liver International · 2025
DOI: 10.1111/liv.70366 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Liver International, 2025. Verfasst von Yanjin Qin und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Gadolinium DTPA, Liver Neoplasms, Magnetic Resonance Imaging. Die Arbeit nennt 29 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province, Municipality Science and Technology Bureau of Guangzhou.
Abstract (Originalsprache)
Objectives
The diagnostic performance of the Liver Imaging Reporting and Data System (LI‐RADS) version 2018 (v2018), its modifications modified LI‐RADS (mLI‐RADS) and revised LI‐RADS (rLI‐RADS), for diagnosing hepatocellular carcinoma (HCC) remains poorly understood and requires further validation. This multicentre study aimed to evaluate the diagnostic performance of three algorithms in diagnosing HCC.
Methods
We included 1092 untreated patients at risk for developing HCC who underwent gadoxetic acid–enhanced MRI across three independent cohorts from January 2020 to December 2022. Two readers independently interpreted each hepatic lesion and recorded their imaging features. The readers' judgements regarding whether the lesion was HCC or not were also noted. Non‐HCC cases were confirmed based on histologic and clinical follow‐up data, while HCC cases were pathologically confirmed. Diagnostic performance metrics were compared using bootstrap resampling and generalised estimating equations. Additionally, the diagnostic odds ratio (DOR) was evaluated.
Results
Of 1313 lesions, 52.3% (687/1313) were diagnosed as HCC. For all hepatic lesions, mLI‐RADS achieved higher sensitivity (82.9%) and accuracy (84.1%) than LI‐RADS v2018 (sensitivity, 79.9%, p = 0.024; accuracy, 83.2%) and rLI‐RADS (sensitivity, 81.3%; accuracy, 83.8%), while maintaining a similar positive predictive value (mLI‐RADS, 86.2%; LI‐RADS v2018, 86.9%; rLI‐RADS, 86.9%). The DORs were 28.3 (95% CI: 21.1–38.0) for mLI‐RADS, 27.8 (95% CI: 20.6–37.7) for LI‐RADS v2018 and 26.0 (95% CI: 19.3–35.0) for rLI‐RADS. The readers' judgement exhibited higher accuracy than that of three algorithms (87.7%: 83.2%–84.1%).
Conclusion
For the diagnosis of HCC in an HBV‐predominant cohort, mLI‐RADS showed higher performance compared with LI‐RADS v2018 and rLI‐RADS. Reader judgement achieved higher accuracy than all algorithms, highlighting the role of clinical expertise. Trial Registration NCT06663904
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
- Department of Medical Imaging Center, Nanfang Hospital, Southern Medical University, Guangzhou, China.
- Department of Radiology, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, China.
ORCID-Profile: Jing Zhang, Shi-Ting Feng
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
- Municipality Science and Technology Bureau of Guangzhou
Zitieren
APA
Qin, Y., Zhang, J., Xu, D., Zhou, X., Ling, Z., Li, L., Zhao, Q., Dong, Z., Wang, J., Cai, H. S., Li, H., Zhang, L. G., & Feng, S. T. (2025). Diagnosis of Hepatocellular Carcinoma Using Gadoxetic Acid‐Enhanced MRI Based on LI ‐ RADS Version 2018 and LI ‐ RADS Modifications. Liver International. https://doi.org/10.1111/liv.70366
Vancouver
Qin Y, Zhang J, Xu D, Zhou X, Ling Z, Li L, et al. Diagnosis of Hepatocellular Carcinoma Using Gadoxetic Acid‐Enhanced MRI Based on LI ‐ RADS Version 2018 and LI ‐ RADS Modifications. Liver International. 2025. doi:10.1111/liv.70366
BibTeX
@article{Qin2025,
author = {Qin, Yanjin and Zhang, Jing and Xu, Danyang and Zhou, Xiaoqi and Ling, Zhoukun and Li, Lujie and Zhao, Qiaochu and Dong, Zhi and Wang, Jifei and Cai, Hua-Song and Li, Hongxiang and Zhang, Lie-Guang and Feng, Shi-Ting},
title = {Diagnosis of Hepatocellular Carcinoma Using Gadoxetic Acid‐Enhanced MRI Based on LI ‐ RADS Version 2018 and LI ‐ RADS Modifications},
journal = {Liver International},
year = {2025},
doi = {10.1111/liv.70366}
}
EUVIMED